| Symbol | AKR |
|---|---|
| Name | ACADIA REALTY TRUST |
| Sector | REAL ESTATE |
| Region | North America |
| Industry | Real Estate Investment Trusts |
| Address | 411 THEODORE FREMD AVENUE,SUITE 300, RYE, New York, 10580, United States |
| Telephone | +1 914 - 288-8100 |
| Fax | — |
| — | |
| Website | https://www.acadiarealty.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0000899629 |
| Description | Acadia Pharmaceuticals is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecule drugs that address disorders such as Parkinsons, Alzheimers, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The companys patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology. Additional info from NASDAQ: |
Acadia Realty Trust to Present at BofA Securities 2026 Global Real Estate Conference
Read moreNew Form SCHEDULE 13G - ACADIA REALTY TRUST <b>Filed:</b> 2026-08-07 <b>AccNo:</b> 0000093751-26-000401 <b>Size:</b> 8 KB
Read moreNew Form SCHEDULE 13G/A - ACADIA REALTY TRUST <b>Filed:</b> 2026-07-31 <b>AccNo:</b> 0002100119-26-001314 <b>Size:</b> 7 KB
Read more(30% Negative) ACADIA REALTY TRUST (AKR) Reports Q3 2026 Financial Results
Read moreAcadia Realty Trust to Announce Second Quarter 2026 Earnings on July 28, 2026
Read moreNew Form 424B5 - ACADIA REALTY TRUST <b>Filed:</b> 2026-06-11 <b>AccNo:</b> 0001104659-26-072692 <b>Size:</b> 1 MB
Read moreAcadia Realty Trust Announces Pricing of Offering of 9,000,000 Common Shares
Read moreAcadia Realty Trust To Present at NAREIT’s REITweek®: 2026 Investor Conference
Read more